[Clinical assessment of Uro-Vaxom in the treatment and prophylaxis of recurrent urinary tract infection in children: preliminary results].
The aim of the study was to determine the efficiency of Uro-Vaxom in the treatment of recurrent urinary tract infection in children. We examined 19 girls in aged 4-17 years treated in our Department since Jan 1998 until Jan 1999 for of recurrent urinary tract infection induced by E. coli (RUTI). All girls have been cured with Uro-Vaxom in single daily dose for 3 months. Disappearance of RUTI in 47% of children and decrease in RUTI in 42% reveals that Uro-Vaxom plays significant role in the treatment of this disease.
Goszczyk
A
A
Klinika Pediatrii i Nefrologii Dzieciecej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej w Warszawie.
Bochniewska
V
V
Jung
A
A
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004926:Escherichia coli; D004927:Escherichia coli Infections; D005260:Female; D006801:Humans; D012008:Recurrence; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000276:Adjuvants, Immunologic; D000892:Anti-Infective Agents, Urinary